[1] Frangež R, Kosec M, Sedmak B, et al. Subchronic liver injuries caused by microcystins. Pflügers Arch, 2000; 440, R103−4.
[2] Fawell JK, Mitchell RE, Everett DJ, et al. The toxicity of cyanobacterial toxins in the mouse: I microcystin-LR. Hum Exp Toxicol, 1999; 18, 162−7. doi:  10.1177/096032719901800305
[3] Chen G, Yu SZ, Wei GR, et al. Studies on microcystin contents in different drinking water in highly endemic area of liver cancer. Chin J Prev Med, 1996; 30, 6−9. (In Chinese
[4] He J, Li GY, Chen J, et al. Prolonged exposure to low-dose microcystin induces nonalcoholic steatohepatitis in mice: a systems toxicology study. Arch Toxicol, 2017; 91, 465−80. doi:  10.1007/s00204-016-1681-3
[5] Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet, 2011; 377, 557−67. doi:  10.1016/S0140-6736(10)62037-5
[6] Wang Q, Niu Y, Xie P, et al. Factors affecting temporal and spatial variations of microcystins in Gonghu Bay of Lake Taihu, with potential risk of microcystin contamination to human health. Sci World J, 2010; 10, 348387.
[7] Zhang XJ, Chen C, Ding JQ, et al. The 2007 water crisis in Wuxi, China: analysis of the origin. J Hazard Mater, 2010; 182, 130−5. doi:  10.1016/j.jhazmat.2010.06.006
[8] Grabner GF, Xie H, Schweiger M, et al. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab, 2021; 3, 1445−65. doi:  10.1038/s42255-021-00493-6
[9] Du C, Zheng SL, Yang Y, et al. Chronic exposure to low concentration of MC-LR caused hepatic lipid metabolism disorder. Ecotoxicol Environ Saf, 2022; 239, 113649. doi:  10.1016/j.ecoenv.2022.113649
[10] Geng YN, Faber KN, de Meijer VE, et al. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?. Hepatol Int, 2021; 15, 21−35. doi:  10.1007/s12072-020-10121-2
[11] Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res, 2020; 126, 1477−500. doi:  10.1161/CIRCRESAHA.120.316101
[12] Hu YF, Chen J, Fan HH, et al. A review of neurotoxicity of microcystins. Environ Sci Pollut Res Int, 2016; 23, 7211−9. doi:  10.1007/s11356-016-6073-y
[13] Wang XJ, Zhang X, Chu ESH, et al. Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis. FASEB J, 2018; 32, 37−51. doi:  10.1096/fj.201601393R
[14] Li Y, Rankin SA, Sinner D, et al. Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signaling. Genes Dev, 2008; 22, 3050−63. doi:  10.1101/gad.1687308
[15] Chatani N, Kamada Y, Kizu T, et al. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int, 2015; 35, 2017−26. doi:  10.1111/liv.12757
[16] Mori H, Prestwich TC, Reid MA, et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest, 2012; 122, 2405−16. doi:  10.1172/JCI63604
[17] Akoumianakis I, Sanna F, Margaritis M, et al. Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases. Sci Transl Med, 2019; 11, eaav5055. doi:  10.1126/scitranslmed.aav5055
[18] Hirosumi J, Tuncman G, Chang L, et al. Author correction: a central role for JNK in obesity and insulin resistance. Nature, 2023; 619, E25.
[19] Pal M, Febbraio MA, Lancaster GI. The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance. J Physiol, 2016; 594, 267−79. doi:  10.1113/JP271457
[20] Wang CP, Yu TH, Wu CC, et al. Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction. Cytokine, 2018; 110, 367−73. doi:  10.1016/j.cyto.2018.04.009
[21] Chen LL, Zhao XL, Liang GJ, et al. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis. Nutr Metab (Lond), 2017; 14, 56. doi:  10.1186/s12986-017-0208-0
[22] Sedan D, Laguens M, Copparoni G, et al. Hepatic and intestine alterations in mice after prolonged exposure to low oral doses of Microcystin-LR. Toxicon, 2015; 104, 26−33. doi:  10.1016/j.toxicon.2015.07.011
[23] Yi XP, Xu SS, Huang FY, et al. Effects of chronic exposure to microcystin-LR on kidney in mice. Int J Environ Res Public Health, 2019; 16, 5030. doi:  10.3390/ijerph16245030
[24] Xu SS, Yi XP, Liu WY, et al. A review of nephrotoxicity of microcystins. Toxins (Basel), 2020; 12, 693. doi:  10.3390/toxins12110693
[25] Jensen-Urstad APL, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?. Biochim Biophys Acta Mol Cell Biol Lipids, 2012; 1821, 747−53.
[26] Wang M, Ma LJ, Yang Y, et al. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Crit Rev Food Sci Nutr, 2019; 59, S116−29. doi:  10.1080/10408398.2018.1544542
[27] ALJohani AM, Syed DN, Ntambi JM. Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism. Trends Endocrinol Metab, 2017; 28, 831−42. doi:  10.1016/j.tem.2017.10.003
[28] Sampath H, Ntambi JM. Role of stearoyl-CoA desaturase-1 in skin integrity and whole body energy balance. J Biol Chem, 2014; 289, 2482−8. doi:  10.1074/jbc.R113.516716
[29] Sheng DD, Zhao SM, Gao L, et al. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Cell Biosci, 2019; 9, 77. doi:  10.1186/s13578-019-0339-2
[30] Chen LY, Duan YQ, Wei HQ, et al. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors. Expert Opin Investig Drugs, 2019; 28, 917−30. doi:  10.1080/13543784.2019.1657825
[31] Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer, 2007; 7, 763−77. doi:  10.1038/nrc2222
[32] Du QQ, Liu P, Zhang CY, et al. FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis. Cell Death Dis, 2022; 13, 488. doi:  10.1038/s41419-022-04926-2
[33] Gonzalez-Bohorquez D, López IMG, Jaeger BN, et al. FASN-dependent de novo lipogenesis is required for brain development. Proc Natl Acad Sci USA, 2022; 119, e2112040119. doi:  10.1073/pnas.2112040119
[34] Gomez-Diaz C, Bargeton B, Abuin L, et al. A CD36 ectodomain mediates insect pheromone detection via a putative tunnelling mechanism. Nat Commun, 2016; 7, 11866. doi:  10.1038/ncomms11866
[35] Chen YL, Zhang J, Cui WG, et al. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med, 2022; 219, e20211314. doi:  10.1084/jem.20211314
[36] Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene, 2017; 36, 1461−73. doi:  10.1038/onc.2016.304
[37] Lin JT, Song T, Li C, et al. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Biochim Biophys Acta Mol Cell Res, 2020; 1867, 118659. doi:  10.1016/j.bbamcr.2020.118659
[38] Ren J, Feng XM, Guo YN, et al. GSK-3β/β-catenin pathway plays crucial roles in the regulation of NK cell cytotoxicity against myeloma cells. FASEB J, 2023; 37, e22821. doi:  10.1096/fj.202201658RR
[39] Sen M, Lauterbach K, El-Gabalawy H, et al. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA, 2000; 97, 2791−6. doi:  10.1073/pnas.050574297
[40] Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab, 2017; 6, 174−84. doi:  10.1016/j.molmet.2016.12.001